[Elsevier] Antibody每drug conjugates after EGFR-TKI resistance in EGFR-mutant NSCLC: Evidence boundaries, post-progression reassessment, and therapeutic sequencing

Eyaddddddddd Post time 6 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-29 03:27
Reward30points

journalㄩCritical Reviews in Oncology/Hematology

AuthorsㄩLinlin Wang; Yong Feng; Renxiang Jia; Qiang Liu

Published dateㄩ2026-10-

DOIㄩ10.1016/j.critrevonc.2026.105661

PDF linkㄩhttps://www.sciencedirect.com/sc ... 040842826005482/pdf

Article linkㄩhttps://doi.org/10.1016/j.critrevonc.2026.105661

Article SourceㄩElsevier BV﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply1 Show all posts
Umarie Post time 5 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    50

Return to the list